Cargando…

The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma

The NOTCH ligands JAG1 and JAG2 have been correlated in vitro with multiple myeloma (MM) cell proliferation, drug resistance, self-renewal and a pathological crosstalk with the tumor microenvironment resulting in angiogenesis and osteoclastogenesis. These findings suggest that a therapeutic approach...

Descripción completa

Detalles Bibliográficos
Autores principales:	Platonova, Natalia, Lazzari, Elisa, Colombo, Michela, Falleni, Monica, Tosi, Delfina, Giannandrea, Domenica, Citro, Valentina, Casati, Lavinia, Ronchetti, Domenica, Bolli, Niccolò, Neri, Antonino, Torricelli, Federica, Crews, Leslie A., Jamieson, Catriona H. M., Chiaramonte, Raffaella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572399/ https://www.ncbi.nlm.nih.gov/pubmed/37834003 http://dx.doi.org/10.3390/ijms241914558

Ejemplares similares

Jagged Ligands Enhance the Pro-Angiogenic Activity of Multiple Myeloma Cells
por: Palano, Maria Teresa, et al.
Publicado: (2020)

Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche
por: Colombo, Michela, et al.
Publicado: (2016)

Multiple myeloma exploits Jagged1 and Jagged2 to promote intrinsic and bone marrow-dependent drug resistance
por: Colombo, Michela, et al.
Publicado: (2020)

Sex Steroid Regulation of Oxidative Stress in Bone Cells: An In Vitro Study
por: Sibilia, Valeria, et al.
Publicado: (2021)

Restoring Tissue Homeostasis at Metastatic Sites: A Focus on Extracellular Vesicles in Bone Metastasis
por: Giannandrea, Domenica, et al.
Publicado: (2021)

Re-establishing Apoptosis Competence in Bone Associated Cancers via Communicative Reprogramming Induced Through Notch Signaling Inhibition
por: Colombo, Michela, et al.
Publicado: (2019)

Identification of small molecules uncoupling the Notch::Jagged interaction through an integrated high-throughput screening
por: Platonova, Natalia, et al.
Publicado: (2017)

P847: BIOLOGICAL AND MOLECULAR CHARACTERIZATION OF IN SILICO IDENTIFIED PUTATIVE INHIBITORS OF PARASPECKLE ASSEMBLY WITH POTENTIAL ANTI-MULTIPLE MYELOMA ACTIVITY.
por: Traini, Valentina, et al.
Publicado: (2023)

Extracellular Vesicles Enhance Multiple Myeloma Metastatic Dissemination
por: Colombo, Michela, et al.
Publicado: (2019)

Extracellular vesicles mediate the communication between multiple myeloma and bone marrow microenvironment in a NOTCH dependent way
por: Giannandrea, Domenica, et al.
Publicado: (2022)

Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins
por: Taiana, Elisa, et al.
Publicado: (2022)

Expression levels of NONO, a nuclear protein primarily involved in paraspeckles function, are associated with several deregulated molecular pathways and poor clinical outcome in multiple myeloma
por: Ronchetti, Domenica, et al.
Publicado: (2022)

DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome
por: Todoerti, Katia, et al.
Publicado: (2021)

Expression Pattern and Biological Significance of the lncRNA ST3GAL6-AS1 in Multiple Myeloma
por: Ronchetti, Domenica, et al.
Publicado: (2020)

Notch signaling deregulation in multiple myeloma: A rational molecular target
por: Colombo, Michela, et al.
Publicado: (2015)

Notch signaling drives multiple myeloma induced osteoclastogenesis
por: Colombo, Michela, et al.
Publicado: (2014)

P849: DEPLETION OF DIS3 IN MULTIPLE MYELOMA LEADS TO PERTURBATION IN RNA METABOLISM, CELL CYCLE PROGRESSION AND MITOTIC CHECKPOINT.
por: Favasuli, V., et al.
Publicado: (2022)

Long non-coding RNAs in B-cell malignancies: a comprehensive overview
por: Nobili, Lucia, et al.
Publicado: (2017)

Reduction of Movement in Neurological Diseases: Effects on Neural Stem Cells Characteristics
por: Adami, Raffaella, et al.
Publicado: (2018)

Transcriptomic Analysis in Multiple Myeloma and Primary Plasma Cell Leukemia with t(11;14) Reveals Different Expression Patterns with Biological Implications in Venetoclax Sensitivity
por: Todoerti, Katia, et al.
Publicado: (2021)

In Silico Characterization of miRNA and Long Non-Coding RNA Interplay in Multiple Myeloma
por: Ronchetti, Domenica, et al.
Publicado: (2016)

Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu
por: Colombo, Michela, et al.
Publicado: (2018)

Long Non-Coding RNAs in Multiple Myeloma
por: Nobili, Lucia, et al.
Publicado: (2018)

Endothelial-Mesenchymal Transition in COVID-19 lung lesions
por: Falleni, Monica, et al.
Publicado: (2021)

A compendium of long non-coding RNAs transcriptional fingerprint in multiple myeloma
por: Ronchetti, Domenica, et al.
Publicado: (2018)

LncRNA NEAT1 in Paraspeckles: A Structural Scaffold for Cellular DNA Damage Response Systems?
por: Taiana, Elisa, et al.
Publicado: (2020)

Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines
por: Mereu, Elisabetta, et al.
Publicado: (2023)

P875: ACTIVATION OF LNCRNA NEAT1 LEADS TO SURVIVAL ADVANTAGE OF MULTIPLE MYELOMA CELLS BY SUPPORTING A REGULATORY LOOP WITH DNA REPAIR PROTEINS: RATIONAL BASES FOR NEAT1 THERAPEUTIC TARGETING IN THE DISEASE
por: Taiana, E., et al.
Publicado: (2022)

An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma
por: Ronchetti, Domenica, et al.
Publicado: (2008)

Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma
por: Ronchetti, Domenica, et al.
Publicado: (2016)

Jagged1 Is Altered in Alzheimer's Disease and Regulates Spatial Memory Processing
por: Marathe, Swananda, et al.
Publicado: (2017)

Jagged-2 (JAG2) enhances tumorigenicity and chemoresistance of colorectal cancer cells
por: Vaish, Vivek, et al.
Publicado: (2017)

Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic Opportunities
por: Botta, Cirino, et al.
Publicado: (2021)

Dissecting the Biological Relevance and Clinical Impact of lncRNA MIAT in Multiple Myeloma
por: Todoerti, Katia, et al.
Publicado: (2021)

Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung
por: Bulfamante, Gaetano, et al.
Publicado: (2021)

Genomics of Smoldering Multiple Myeloma: Time for Clinical Translation of Findings?
por: Lionetti, Marta, et al.
Publicado: (2021)

Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma
por: Stamato, Maria Angelica, et al.
Publicado: (2017)

NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma
por: Fiaschetti, Giulio, et al.
Publicado: (2014)

Assemblies of JAG1 and JAG2 determine tracheobronchial cell fate in mucosecretory lung disease
por: Reynolds, Susan D., et al.
Publicado: (2022)

Chronic Myeloid Leukemia Stem Cell Biology
por: Crews, Leslie A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_sht8qr9vrrm9ntauflot96f3ic